Metahexamide

CAS: 565-33-3

Ref. 3D-FA61379

Produktinformation

• Name: Metahexamide
• Synonyme: 3-Amino-N-[(cyclohexylamino)carbonyl]-4-methylbenzenesulfonamide
• Marke: Biosynth
• Beschreibung: 3-Amino-4-Methylbenzenesulfonylcyclohexylurea (3AMBC) is a drug that is used to treat metabolic disorders, autoimmune diseases, and other conditions. 3AMBC inhibits the production of free fatty acids by binding to the enzyme acyl-CoA synthetase 2 (ACS2). The bound form of 3AMBC has been shown to have a higher affinity for ACP2 than the free form, which may account for its strong inhibition of fatty acid synthesis. 3AMBC also has anti-inflammatory properties and has been shown to inhibit the production of inflammatory cytokines in mice with collagen-induced arthritis. This drug also binds to neutrophils and macrophages, which may account for its anti-inflammatory effects. 3AMBC is an antidiabetic agent that increases glucose uptake in liver cells and improves glucose tolerance in diabetic patients. It also inhibits the release of glucose from the liver into the bloodstream by

Chemische Eigenschaften

• Molekulargewicht: 311.4 g/mol
• Formel: C₁₄H₂₁N₃O₃S
• Reinheit: Min. 95%